Product Reports Resources Pricing Login Book a demo

Huma

Biotech & Life Sciences · London, United Kingdom · Founded 2011

Provides a digital health platform used for predictive care and research

Investors

15 investors on Huma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Iratel Ventures
Dale Ventures
Healthbox
Series A 1 investor entered at this stage
NWS Holdings
Series B+ 11 investors entered at this stage
Michael Diekmann
HAT SGR
Unilever Ventures
Tech Nation
Nikesh Arora
Bayer
AstraZeneca
Sony Innovation Fund
Samsung Next
Leaps by Bayer
Hitachi

Global footprint

Where Huma has talent and traffic

Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown
Web traffic by country
33K monthly visits
across markets
🇬🇧 United Kingdom17%
🇺🇸 United States14.8%
🇳🇴 Norway10.9%
🇦🇺 Australia10%
🇨🇦 Canada9.4%
Top 5 markets shown

Talent graph

The shape of Huma's talent

Dealroom maps Huma's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

12 standout operatorsDealroom-flagged across the org
7 AI specialistsincl. 4 core researchers
284 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Huma's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Capital deployed

Huma's 6 investments and acquisitions.

Every disclosed deal where Huma appeared as a backer or acquirer, 2018–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Huma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Huma's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Huma

        An AI-synthesized read of the highest-engagement posts about Huma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Huma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.